pharmaceutical research


CureLauncher To Boost Fundriaising, Study Participation For Early Stage Pharma

Many American medical innovations, including possible new drugs and medical devices, can’t raise the money needed for early stage testing. Now there is a way for every affected person to help those dedicated scientists receive the funds needed to make the next medical breakthrough.

WWJ Newsradio 950–11/15/2012

Synthetics Biologics

Synthetic Biologics Launches Free Investor Relations Mobile Application

Synthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the “SYN IR” App, now available for free at the Apple App Store on the iPhone or iPad or at

WWJ Newsradio 950–04/26/2012

GeneGo's ToxHunter Suite Now Available

St. Joseph-based GeneGo this week announced the availability of ToxHunter, the first commercial release of tools and content developed through its industry-FDA MetaTox partnership program. ToxHunter is a unique comprehensive systems toxicology suite designed for […]